Salvador
Resino García
Publicacións nas que colabora con Salvador Resino García (30)
2011
2008
-
Immunological recovery and metabolic disorders in severe immunodeficiency HIV type 1-infected children on highly active antiretroviral therapy
AIDS Research and Human Retroviruses, Vol. 24, Núm. 12, pp. 1477-1484
-
Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children
Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 1, pp. 183-190
2007
-
Carga viral plasmática en niños infectados por el virus de la inmunodeficiencia humana que reciben tratamiento antirretroviral de gran actividad
Medicina Clinica, Vol. 128, Núm. 2, pp. 49-51
2006
-
CD4+ T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy
Journal of Acquired Immune Deficiency Syndromes, Vol. 42, Núm. 3, pp. 269-276
-
Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
BMC Infectious Diseases, Vol. 6
-
Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy
BMC Infectious Diseases, Vol. 6
-
Interleukin-7 levels before highly active antiretroviral therapy may predict CD4+ T-cell recovery and virological failure in HIV-infected children [5]
Journal of Antimicrobial Chemotherapy
-
La terapia combinada puede ser tan efectiva como la terapia antirretroviral de alta eficacia en el control de la carga viral en niños con un sistema inmunitario conservado
Acta Pediatrica Espanola, Vol. 64, Núm. 8, pp. 377-382
-
Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 Years of follow-up
Clinical Infectious Diseases, Vol. 42, Núm. 6, pp. 862-869
-
Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiency
Pediatric Infectious Disease Journal, Vol. 25, Núm. 4, pp. 365-368
2004
-
HIV-infected children with moderate/severe immune-suppression: Changes in the immune system after highly active antiretroviral therapy
Clinical and Experimental Immunology, Vol. 137, Núm. 3, pp. 570-577
2003
-
CD8+ T-cell numbers predict the response to antiviral therapy in HIV-1-infected children
Pediatric Research, Vol. 53, Núm. 2, pp. 309-312
-
Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children
Journal of Clinical Immunology, Vol. 23, Núm. 4, pp. 279-289
-
Recien nacidos con edad gestacional <26 semanas frente a recien nacidos entre las semanas 26-28
Acta pediátrica española, Vol. 61, Núm. 2, pp. 83
-
Recién nacidos con edad gestacional <26 semanas frente a recién nacidos entre las semanas 26-28
Acta Pediatrica Espanola, Vol. 61, Núm. 2, pp. 83-87
-
Recovery of T-cell subsets after antiretroviral therapy in HIV-infected children
European Journal of Clinical Investigation, Vol. 33, Núm. 7, pp. 619-627
-
Viral Load and CD4+ T Lymphocyte Response to Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children: An Observational Study
Clinical Infectious Diseases, Vol. 37, Núm. 9, pp. 1216-1225
2002
-
Different immune profiles acccording to the immunological and clinical progression in vertically HIV-infected children
Medicina Clinica, Vol. 118, Núm. 7, pp. 241-246
-
Dynamics of progression markers in a non-study population of human immunodeficiency virus-1 vertically infected infants with different antiretroviral treatments
Acta Paediatrica, International Journal of Paediatrics, Vol. 91, Núm. 7, pp. 776-782